- Report
- October 2025
- 279 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,029GBP
- Report
- July 2025
- 387 Pages
Global
From €1177EUR$1,362USD£1,000GBP
- Report
- August 2025
- 296 Pages
Global
From €4428EUR$4,950USD£3,895GBP
- Report
- July 2025
- 1219 Pages
Global
From €1412EUR$1,634USD£1,200GBP
- Report
- December 2024
- 1214 Pages
Global
From €1412EUR$1,634USD£1,200GBP
- Report
- October 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- August 2025
- 122 Pages
Global
From €2280EUR$2,549USD£2,006GBP
€2682EUR$2,999USD£2,360GBP
- Report
- May 2025
- 141 Pages
Global
From €2280EUR$2,549USD£2,006GBP
€2682EUR$2,999USD£2,360GBP
- Report
- September 2025
- 150 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- July 2025
- 150 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- February 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- August 2025
- 180 Pages
Global
From €4025EUR$4,500USD£3,541GBP
- Report
- October 2025
- 195 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 186 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- April 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- April 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- June 2025
- 400 Pages
Global
From €4427EUR$4,949USD£3,894GBP
- Report
- June 2025
- 245 Pages
Global
From €4468EUR$4,995USD£3,930GBP
- Report
- October 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,029GBP

The Wearable Cardioverter Defibrillator (WCD) is a type of cardiovascular device used to detect and treat life-threatening arrhythmias. It is worn on the body and is designed to detect and treat ventricular tachycardia and ventricular fibrillation. The device is typically used in patients who are at risk of sudden cardiac arrest, such as those with a history of heart failure or a previous cardiac arrest. It is also used in patients who have had an implantable cardioverter defibrillator (ICD) removed due to complications.
The WCD market is growing due to the increasing prevalence of cardiovascular diseases and the need for improved patient care. The device is also becoming more widely accepted due to its convenience and safety. Additionally, technological advancements have enabled the device to be more accurate and reliable.
Some of the major players in the WCD market include Medtronic, Abbott, Boston Scientific, Biotronik, and Zoll Medical. Show Less Read more